듀켐바이오
176750
🕒 Price Jul 29, 12:30 KST
The overall grade and 100-point score are Premium-only. The 6-metric analysis below is free.
See Premium →Investment caution signals
Automatic signals from DART filings and price trends. “Filing” items are detected from the last 180 days of electronic disclosures. Verify facts against the original filings/news. Not a buy/sell recommendation.
💰 Valuation at a glance
Yahoo FinancePrice ÷ EPS. Lower is cheaper vs earnings. Forward-earnings basis.
📊 Price trend
Open in Multi-chart →Yahoo Finance🎯 7-metric analysis
Based on latest annual results
Value axes (P/E, P/B, EV) are growth- & profitability-adjusted — premium growth names aren’t pinned to zero. (Losses / negative equity stay 0.)
📈 Key metrics
Yahoo Finance🏢 Peer comparison
Pharma / BiotechSide by side with the largest names in the same sector. Green beats the sector median.
| Stock | PER | PBR | ROE | Dividend |
|---|---|---|---|---|
| 듀켐바이오Current | — | — | 13.2% | — |
| ALTEOGEN Inc. | 109.3× | 34.78× | 31.8% | 0.1% |
🏦 Dividend vs deposit rate
This stock pays no dividend (or has no dividend data), so it isn't directly comparable to a deposit rate. It may be a growth name that relies on price appreciation instead.
As of: Bank of Korea weighted-avg deposit rate · 3.00% (2026-05)
📰 Related news
Source: Naver Finance (KR) · Yahoo Finance (US) · external article links
💼 Financial statements
Yahoo FinanceRecent annual
| Period | Revenue | Op. income | Net income | Op. margin |
|---|---|---|---|---|
| 2025 FY | ₩38.6B | ₩7.4B | ₩6.5B | 19.3% |
| 2024 FY | ₩35.6B | ₩5.1B | ₩8.0B | 14.3% |
| 2023 FY | ₩34.7B | ₩5.3B | ₩4.0B | 15.1% |
| 2022 FY | ₩32.4B | ₩1.6B | ₩-2.6B | 4.8% |
Quarterly results (last 5 quarters)
📚 Metrics & scoringShow moreCollapse
🔎 Data sources & methodologyShow moreCollapse
Every score is auto-computed from the public data below. No manual adjustment.
| Item | Source | Method · update cadence |
|---|---|---|
| Price · volume · 52W | Yahoo Finance | Stored as-is · hourly intraday |
| Financials (revenue, profit, equity, debt) | Yahoo fundamentalsTimeSeries | Annual + quarterly reported · refreshed over ~1 week |
| Short-term (TTM) score | Computed (quarterly financials) | Sum of last 4 quarters + YoY momentum vs same quarter a year ago · daily |
| PER · PBR | Computed (KR) | Market cap ÷ latest annual net income / equity · N/A on loss or capital impairment |
| Dividend yield | Yahoo Finance | Annual dividend ÷ price · 0% if none |
| ROE · operating margin · debt ratio |